Ken Coyle
Nessuna posizione attualmente
Profilo
Ken Coyle served as the Chief Executive Officer at Genactis, Inc. He also worked as the Senior Director-Respiratory Biologics Marketing at AstraZeneca PLC and as the Vice President-Sales at Radius Health, Inc. Coyle holds a graduate degree from Rutgers State University of New Jersey and an undergraduate degree from Grinnell College.
Precedenti posizioni note di Ken Coyle
| Società | Posizione | Fine |
|---|---|---|
| ASTRAZENECA PLC | Vendite & Marketing | - |
| Genactis, Inc. | Amministratore Delegato | - |
| RADIUS HEALTH, INC. | Vendite & Marketing | - |
Formazione di Ken Coyle
| Rutgers State University of New Jersey | Graduate Degree |
| Grinnell College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Aziende private | 2 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
| Genactis, Inc. |
- Borsa valori
- Insiders
- Ken Coyle
